Developer docs
API playgroundTry for free, no card

Search company profiles

The Mission Within

Full company profile

uuid003krxa

Namestring
The Mission Within
Legal namestring
Elite Neuro Recovery Center
Company typeenum
Private
Founded yearint
2017
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
psychedelic therapy services, ibogaine treatment, veteran mental health, trauma recovery program, 5-MeO-DMT therapy
Industry2 codes
PRIMARYTHAGAMAG
Rehabilitation & Recovery Retreats (Physio, Post-Op, Pain Management)
Travel & Hospitality/Lodging & Accommodation/Wellness, Spa & Health Retreats
SECONDARYTHAGAMAI
Holistic & Alternative Therapy Retreats (Naturopathy, Energy Work)
Travel & Hospitality/Lodging & Accommodation/Wellness, Spa & Health Retreats
NAICS code1 code
  • Residential Mental Health and Substance Abuse Facilities623220
SIC code2 codes
  • Services-Health Services8000
  • Hotels, Rooming Houses, Camps & Other Lodging Places7000
Product category
Psychedelic Therapy Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Treatment Program Fees
TypeOne Time License
Description

The primary revenue stream comes from fees charged for the comprehensive 6-week clinical psychedelic program, which includes preparation coaching, the in-person medicine retreat with Ibogaine and 5-MeO treatments, integration coaching, room and board, 24-hour medical support, and transportation from San Diego. Pricing varies by customer segment: $6,500 for US Veterans and $7,500 for Civilians, plus a $75 initial Health Screen fee.

missionwithin.org
2Donations and Foundation Support
TypeAffiliate Referral
Description

The company raises funds through Mission to Live Foundation, a nonprofit that provides scholarships and financial assistance for veterans and first responders who cannot afford the treatment fee. Donations are accepted via the foundation's website.

missionwithin.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details4 tiers
1US Veterans Program - Full 6-week clinical psychedelic treatment including preparation, 5-day in-person retreat with Ibogaine and 5-MeO, integration coaching, and aftercare
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$6,500 for US Veterans. Includes treatment, preparation coaching, integration coaching, preparation and integration workbook, transportation from San Diego, room & board, and 24-hour medical and therapeutic support. Additional $75 initial Health Screen fee.

missionwithin.org
2Civilian Program - Full 6-week clinical psychedelic treatment including preparation, 5-day in-person retreat with Ibogaine and 5-MeO, integration coaching, and aftercare
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$7,500 for Civilians. Includes treatment, preparation coaching, integration coaching, preparation and integration workbook, transportation from San Diego, room & board, and 24-hour medical and therapeutic support. Additional $75 initial Health Screen fee.

missionwithin.org
3Health Screening Fee
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$75 initial Health Screen fee for all participants.

missionwithin.org
4Veterans/First Responder Financial Assistance
ModelOtherBilling cadencePay-as-you-go
Notes

Veterans or first responders who cannot afford the retreat fee are directed to contact Mission Within Foundation for potential scholarship support.

missionwithin.org
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Mission to Live Foundation
Description

Nonprofit foundation established in 2025 to raise funds for scholarships and support cutting-edge research for psychedelic therapy access for veterans and first responders.

missionwithin.org
Core offering1 text field

The Mission Within provides a 6-week clinical psychedelic therapy program that pairs online preparation coaching, a 5-day in-person medicine retreat, and post-retreat integration coaching. The in-person retreat uses sequential administration of Ibogaine and 5-MeO-DMT under 24-hour medical supervision to treat PTSD, mTBI, depression, anxiety, and addiction in veterans, first responders, military families, and high-performance individuals. The program is delivered at a facility in coastal Mexico near San Diego.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 80% of participants no longer meet diagnostic criteria for PTSD after treatment
+5 more records
Product overview1 text field

The Mission Within offers a single unified clinical offering: the 6-Week Clinical Psychedelic Program, which pairs online therapy, coaching, preparation, and integration with a 5-day in-person medicine retreat in Mexico. The core treatment protocol centers on two psychedelic medicines — Ibogaine (administered in an overnight ceremony) and 5-MeO (administered in individual inhalation sessions) — used sequentially, with psilocybin also mentioned as part of the entheogen portfolio. The program is supported by structured add-on modules: Preparation Coaching (minimum 2 sessions), Integration Coaching (minimum 3 sessions), a Preparation and Integration Workbook, and Aftercare Resources & Community. The organization also operates two supplemental initiatives: Healing Across Borders (a humanitarian program for conflict-affected populations globally) and Mission to Live Foundation (a nonprofit scholarship and research fund). Together, these form a clinical treatment program built around the sequential Ibogaine + 5-MeO protocol pioneered by Dr. Martín Polanco.

Product and service6 records
16-Week Clinical Psychedelic Program
CategoryClinical Treatment Program
Description

A 6-week clinical psychedelic program pairing online therapy, coaching, preparation, and integration with a 5-day in-person medicine retreat in Mexico, using sequential Ibogaine and 5-MeO-DMT treatments within a trauma-informed, peer-community framework. Priced at $6,500 for US Veterans and $7,500 for Civilians, plus a $75 Health Screen fee. Designed for individuals dealing with PTSD, mTBI, depression, anxiety, and addiction who have not found relief through conventional medicine.

2Ibogaine Treatment
CategoryPsychedelic Medicine Treatment
Description

A clinical treatment using ibogaine, an alkaloid derived from the root bark of Tabernanthe iboga, administered in a long (24+ hour) ceremony to address addiction, PTSD, and traumatic brain injury. Forms the first stage of The Mission Within's sequential protocol.

35-MeO Treatment
CategoryPsychedelic Medicine Treatment
Description

A clinical treatment using 5-MeO-DMT, a fast-acting psychedelic typically inhaled as vaporized toad-derived or synthetic material, administered in individual sessions to produce ego dissolution and mystical experiences for PTSD, depression, and trauma recovery. Delivered as the second stage of the sequential Ibogaine + 5-MeO protocol.

4Psilocybin Treatment
CategoryPsychedelic Medicine Treatment
Description

A clinical treatment using psilocybin, a psychedelic compound found in Psilocybe mushrooms, used in The Mission Within's treatments alongside Ibogaine and 5-MeO-DMT and subject to the same waiver and safety protocols.

5Healing Across Borders
CategoryHumanitarian Program
Description

A humanitarian initiative providing trauma recovery services for individuals impacted by war and conflict worldwide, including Israeli veterans and civilians, and Palestinian civilians and refugees, delivered through regionally focused treatment cohorts that meet medical and safety criteria.

6Mission to Live Foundation Scholarship Program
CategoryNonprofit Scholarship Program
Description

A nonprofit foundation that provides scholarships and financial assistance for veterans and first responders to access The Mission Within's treatment program, and supports cutting-edge psychedelic research. Operated as a separate 501(c)(3) entity under the Mission to Live Foundation brand.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
1UT Austin Dell Medical School - Center for Psychedelic Research and Therapy
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Active research partnership examining how ibogaine and psilocybin affect brain function and mental health outcomes in veterans and military-connected communities. Two ongoing studies: (1) Ibogaine Study for Special Operations Veterans examining neurological and psychological effects with longer assessment timelines and ibogaine-only controls, (2) Psilocybin Therapy for Surviving Family Members examining brain function and grief recovery with MRI imaging.

missionwithin.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on research examining outcomes related to PTSD, mTBI, and alcohol use disorder. Dr. Polanco has presented findings at Stanford and collaborated with researchers from the Brain Stimulation Lab.

3Harvard Medical School
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative research relationship on studying outcomes related to PTSD, mTBI, and related conditions in veteran populations.

missionwithin.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic collaboration on research studying outcomes related to PTSD, mTBI, and trauma in veteran populations.

5National Intrepid Center of Excellence (NICoE)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Presentation and collaboration with NICoE, which is part of the Defense Health Agency focused on traumatic brain injury and psychological health for service members.

missionwithin.org
6Mission to Live Foundation
Strategic tierCoreTypeGTM or Marketing Partner
Description

Nonprofit founded by Dr. Polanco in 2025 to remove financial barriers to treatment for veterans and first responders. The foundation raises funds for scholarships, contributes to cutting-edge research, and advocates for greater accessibility to psychedelic therapy.

missionwithin.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Former clinic operated by Dr. Polanco in Tijuana (2012) where early research on ibogaine and 5-MeO was conducted. Dr. Joseph Barsuglia was recruited as Research Director in 2015 to begin systematic data collection.

8Ibogaine Association (Mexico)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

One of the first medically supervised ibogaine clinics on the American continent, co-founded by Dr. Polanco in 2000.

missionwithin.org
9Special Operations Medical Association (SOMA)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Presented research findings at the SOMA Scientific Assembly on psychedelic treatment outcomes for Special Operations Forces veterans.

missionwithin.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Presented findings on psychedelic treatment for trauma at Department of Defense forums and grand rounds.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Polanco presented findings at the World Economic Forum, positioning the organization's work in the global health policy conversation.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1MindMed
TypeEmerging player
Description

Public psychedelic medicine company developing LSD and MDMA-based therapies for anxiety, ADHD, and other conditions. Comparable as a regulated psychedelic clinical developer pursuing FDA pathways; differs from Mission Within in targeting outpatient drug development rather than retreat-based delivery.

TypeOthers
Description

Academic research group at Stanford Medicine studying psilocybin and other psychedelics for psychiatric conditions. Listed as a research partner of The Mission Within and a comparable node in the academic psychedelic research ecosystem.

TypeOthers
Description

Nonprofit research organization that pioneered MDMA-assisted therapy clinical trials and PTSD research. Comparable as a leading psychedelic research and advocacy organization with veteran PTSD focus; differs as a research/advocacy nonprofit rather than a treatment provider.

TypeEmerging player
Description

Public clinical-stage psychedelic medicine company developing psilocybin therapy for treatment-resistant depression. Comparable as a regulated, well-capitalized psychedelic therapy developer targeting psychiatric indications, though focused on psilocybin rather than ibogaine/5-MeO and based in the UK/US rather than a Mexico retreat.

TypeBroad incumbent
Description

US ketamine therapy provider delivering at-home and clinic-based sessions for depression, anxiety, and PTSD. Comparable as a scaled psychedelic-adjacent therapy provider targeting mental health; differs by using ketamine (legal in US) rather than ibogaine, with a more distributed clinic model.

6atai Life Sciences
TypeEmerging player
Description

Public platform company developing multiple psychedelic compounds (psilocybin, DMT, ibogaine derivatives) for mental health. Comparable as a well-capitalized ibogaine-adjacent developer; differs from Mission Within as a clinical-stage pharma platform rather than a retreat operator.

TypeDirect peer
Description

Mexico-based medically supervised ibogaine treatment center for addiction and mental health conditions. Most directly comparable peer: same compound (ibogaine), similar location (Mexico), similar clinical retreat model, and overlapping customer segments including veterans and trauma patients.

8Clear Sky Recovery
TypeDirect peer
Description

Ibogaine-focused addiction treatment clinic in Cancun, Mexico. Directly comparable as a Mexico-based ibogaine clinic offering supervised treatment for substance use disorders; smaller scale and less veteran focus than Mission Within.

9Field Trip Health (now Field Trip)
TypeDirect peer
Description

Previously operated ketamine-assisted psychotherapy clinics across North America before restructuring. Comparable as a clinic-based psychedelic therapy operator pursuing trauma and depression indications; differs in compound (ketamine), geographic footprint, and operational scale.

TypeRegional player
Description

Nonprofit network of mental health clinics providing free therapy to veterans and military families across the US. Comparable as a veteran-focused mental health provider; differs by offering conventional outpatient therapy rather than psychedelic-assisted treatment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses6 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Mission Within

Psychedelic Therapy Servicesmissionwithin.org

The Mission Within firmographics

Firmographics
Name
The Mission Within
Legal name
Elite Neuro Recovery Center
Website
https://missionwithin.org
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

The Mission Within industry classification

Industry
Product category
Psychedelic Therapy Services
NAICS
Residential Mental Health and Substance Abuse Facilities (623220)
SIC
Services-Health Services (8000), Hotels, Rooming Houses, Camps & Other Lodging Places (7000)
akta.pro industry
PRIMARYTHAGAMAG
Rehabilitation & Recovery Retreats (Physio, Post-Op, Pain Management)
Travel & Hospitality/Lodging & Accommodation/Wellness, Spa & Health Retreats
SECONDARYTHAGAMAI
Holistic & Alternative Therapy Retreats (Naturopathy, Energy Work)
Travel & Hospitality/Lodging & Accommodation/Wellness, Spa & Health Retreats

Keywords

  • Psychedelic therapy services
  • Ibogaine treatment
  • Veteran mental health
  • Trauma recovery program
  • 5-MeO-DMT therapy

Where The Mission Within is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

The Mission Within business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Clinical Treatment Program Fees: The primary revenue stream comes from fees charged for the comprehensive 6-week clinical psychedelic program, which includes preparation coaching, the in-person medicine retreat with Ibogaine and 5-MeO treatments, integration coaching, room and board, 24-hour medical support, and transportation from San Diego. Pricing varies by customer segment: $6,500 for US Veterans and $7,500 for Civilians, plus a $75 initial Health Screen fee.
  2. Donations and Foundation Support: The company raises funds through Mission to Live Foundation, a nonprofit that provides scholarships and financial assistance for veterans and first responders who cannot afford the treatment fee. Donations are accepted via the foundation's website.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goUS Veterans Program - Full 6-week clinical psychedelic treatment including preparation, 5-day in-person retreat with Ibogaine and 5-MeO, integration coaching, and aftercare
Unit PricingPay-as-you-goCivilian Program - Full 6-week clinical psychedelic treatment including preparation, 5-day in-person retreat with Ibogaine and 5-MeO, integration coaching, and aftercare
Unit PricingPay-as-you-goHealth Screening Fee
OtherPay-as-you-goVeterans/First Responder Financial Assistance

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

The Mission Within product offering

Product offering

Core offering

The Mission Within provides a 6-week clinical psychedelic therapy program that pairs online preparation coaching, a 5-day in-person medicine retreat, and post-retreat integration coaching. The in-person retreat uses sequential administration of Ibogaine and 5-MeO-DMT under 24-hour medical supervision to treat PTSD, mTBI, depression, anxiety, and addiction in veterans, first responders, military families, and high-performance individuals. The program is delivered at a facility in coastal Mexico near San Diego.

Product overview

The Mission Within offers a single unified clinical offering: the 6-Week Clinical Psychedelic Program, which pairs online therapy, coaching, preparation, and integration with a 5-day in-person medicine retreat in Mexico. The core treatment protocol centers on two psychedelic medicines — Ibogaine (administered in an overnight ceremony) and 5-MeO (administered in individual inhalation sessions) — used sequentially, with psilocybin also mentioned as part of the entheogen portfolio. The program is supported by structured add-on modules: Preparation Coaching (minimum 2 sessions), Integration Coaching (minimum 3 sessions), a Preparation and Integration Workbook, and Aftercare Resources & Community. The organization also operates two supplemental initiatives: Healing Across Borders (a humanitarian program for conflict-affected populations globally) and Mission to Live Foundation (a nonprofit scholarship and research fund). Together, these form a clinical treatment program built around the sequential Ibogaine + 5-MeO protocol pioneered by Dr. Martín Polanco.

Differentiator

Problem solved

Functional benefit

Brands

  • Mission to Live Foundation: Nonprofit foundation established in 2025 to raise funds for scholarships and support cutting-edge research for psychedelic therapy access for veterans and first responders.

Products and services

  • 6-Week Clinical Psychedelic Program A 6-week clinical psychedelic program pairing online therapy, coaching, preparation, and integration with a 5-day in-person medicine retreat in Mexico, using sequential Ibogaine and 5-MeO-DMT treatments within a trauma-informed, peer-community framework. Priced at $6,500 for US Veterans and $7,500 for Civilians, plus a $75 Health Screen fee. Designed for individuals dealing with PTSD, mTBI, depression, anxiety, and addiction who have not found relief through conventional medicine.
  • Ibogaine Treatment A clinical treatment using ibogaine, an alkaloid derived from the root bark of Tabernanthe iboga, administered in a long (24+ hour) ceremony to address addiction, PTSD, and traumatic brain injury. Forms the first stage of The Mission Within's sequential protocol.
  • 5-MeO Treatment A clinical treatment using 5-MeO-DMT, a fast-acting psychedelic typically inhaled as vaporized toad-derived or synthetic material, administered in individual sessions to produce ego dissolution and mystical experiences for PTSD, depression, and trauma recovery. Delivered as the second stage of the sequential Ibogaine + 5-MeO protocol.
  • Psilocybin Treatment A clinical treatment using psilocybin, a psychedelic compound found in Psilocybe mushrooms, used in The Mission Within's treatments alongside Ibogaine and 5-MeO-DMT and subject to the same waiver and safety protocols.
  • Healing Across Borders A humanitarian initiative providing trauma recovery services for individuals impacted by war and conflict worldwide, including Israeli veterans and civilians, and Palestinian civilians and refugees, delivered through regionally focused treatment cohorts that meet medical and safety criteria.
  • Mission to Live Foundation Scholarship Program A nonprofit foundation that provides scholarships and financial assistance for veterans and first responders to access The Mission Within's treatment program, and supports cutting-edge psychedelic research. Operated as a separate 501(c)(3) entity under the Mission to Live Foundation brand.

Quantifiable outcome

  • 80% of participants no longer meet diagnostic criteria for PTSD after treatment
  • +5 more outcomes

Companies that use The Mission Within

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles4 records

The Mission Within technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

The Mission Within partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • UT Austin Dell Medical School - Center for Psychedelic Research and TherapycoreStrategic or Co-development Partner · 1 January 2024Active research partnership examining how ibogaine and psilocybin affect brain function and mental health outcomes in veterans and military-connected communities. Two ongoing studies: (1) Ibogaine Study for Special Operations Veterans examining neurological and psychological effects with longer assessment timelines and ibogaine-only controls, (2) Psilocybin Therapy for Surviving Family Members examining brain function and grief recovery with MRI imaging.
  • Stanford UniversitycoreStrategic or Co-development PartnerCollaboration on research examining outcomes related to PTSD, mTBI, and alcohol use disorder. Dr. Polanco has presented findings at Stanford and collaborated with researchers from the Brain Stimulation Lab.
  • Harvard Medical SchoolcoreStrategic or Co-development PartnerCollaborative research relationship on studying outcomes related to PTSD, mTBI, and related conditions in veteran populations.
  • Yale UniversitycoreStrategic or Co-development PartnerAcademic collaboration on research studying outcomes related to PTSD, mTBI, and trauma in veteran populations.
  • National Intrepid Center of Excellence (NICoE)coreStrategic or Co-development PartnerPresentation and collaboration with NICoE, which is part of the Defense Health Agency focused on traumatic brain injury and psychological health for service members.
  • Mission to Live FoundationcoreGTM or Marketing PartnerNonprofit founded by Dr. Polanco in 2025 to remove financial barriers to treatment for veterans and first responders. The foundation raises funds for scholarships, contributes to cutting-edge research, and advocates for greater accessibility to psychedelic therapy.
  • Crossroads Treatment CenterminorStrategic or Co-development PartnerFormer clinic operated by Dr. Polanco in Tijuana (2012) where early research on ibogaine and 5-MeO was conducted. Dr. Joseph Barsuglia was recruited as Research Director in 2015 to begin systematic data collection.
  • Ibogaine Association (Mexico)minorStrategic or Co-development PartnerOne of the first medically supervised ibogaine clinics on the American continent, co-founded by Dr. Polanco in 2000.
  • Special Operations Medical Association (SOMA)minorStrategic or Co-development PartnerPresented research findings at the SOMA Scientific Assembly on psychedelic treatment outcomes for Special Operations Forces veterans.
  • U.S. Department of DefenseminorStrategic or Co-development PartnerPresented findings on psychedelic treatment for trauma at Department of Defense forums and grand rounds.
  • World Economic ForumminorStrategic or Co-development PartnerDr. Polanco presented findings at the World Economic Forum, positioning the organization's work in the global health policy conversation.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

The Mission Within competitors and assessment

Company assessment

Emerging players

  • MindMed: Public psychedelic medicine company developing LSD and MDMA-based therapies for anxiety, ADHD, and other conditions. Comparable as a regulated psychedelic clinical developer pursuing FDA pathways; differs from Mission Within in targeting outpatient drug development rather than retreat-based delivery.
  • Compass Pathways: Public clinical-stage psychedelic medicine company developing psilocybin therapy for treatment-resistant depression. Comparable as a regulated, well-capitalized psychedelic therapy developer targeting psychiatric indications, though focused on psilocybin rather than ibogaine/5-MeO and based in the UK/US rather than a Mexico retreat.
  • atai Life Sciences: Public platform company developing multiple psychedelic compounds (psilocybin, DMT, ibogaine derivatives) for mental health. Comparable as a well-capitalized ibogaine-adjacent developer; differs from Mission Within as a clinical-stage pharma platform rather than a retreat operator.

Others

  • Stanford Psychedelic Science Group: Academic research group at Stanford Medicine studying psilocybin and other psychedelics for psychiatric conditions. Listed as a research partner of The Mission Within and a comparable node in the academic psychedelic research ecosystem.
  • Multidisciplinary Association for Psychedelic Studies (MAPS): Nonprofit research organization that pioneered MDMA-assisted therapy clinical trials and PTSD research. Comparable as a leading psychedelic research and advocacy organization with veteran PTSD focus; differs as a research/advocacy nonprofit rather than a treatment provider.

Broad incumbents

  • Mindbloom: US ketamine therapy provider delivering at-home and clinic-based sessions for depression, anxiety, and PTSD. Comparable as a scaled psychedelic-adjacent therapy provider targeting mental health; differs by using ketamine (legal in US) rather than ibogaine, with a more distributed clinic model.

Direct peers

  • Beond Ibogaine: Mexico-based medically supervised ibogaine treatment center for addiction and mental health conditions. Most directly comparable peer: same compound (ibogaine), similar location (Mexico), similar clinical retreat model, and overlapping customer segments including veterans and trauma patients.
  • Clear Sky Recovery: Ibogaine-focused addiction treatment clinic in Cancun, Mexico. Directly comparable as a Mexico-based ibogaine clinic offering supervised treatment for substance use disorders; smaller scale and less veteran focus than Mission Within.
  • Field Trip Health (now Field Trip): Previously operated ketamine-assisted psychotherapy clinics across North America before restructuring. Comparable as a clinic-based psychedelic therapy operator pursuing trauma and depression indications; differs in compound (ketamine), geographic footprint, and operational scale.

Regional players

  • Veterans Healing Network (Cohen Veterans Network): Nonprofit network of mental health clinics providing free therapy to veterans and military families across the US. Comparable as a veteran-focused mental health provider; differs by offering conventional outpatient therapy rather than psychedelic-assisted treatment.

Market position

Strengths5 records

Weaknesses6 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

The Mission Within social profiles

Digital presence

The Mission Within financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Mission Within leadership team

Management profile

Number of profiles

Profiles1 record

The Mission Within funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Mission Within M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Mission Within

What does The Mission Within do?

The Mission Within provides a 6-week clinical psychedelic therapy program that pairs online preparation coaching, a 5-day in-person medicine retreat, and post-retreat integration coaching. The in-person retreat uses sequential administration of Ibogaine and 5-MeO-DMT under 24-hour medical supervision to treat PTSD, mTBI, depression, anxiety, and addiction in veterans, first responders, military families, and high-performance individuals. The program is delivered at a facility in coastal Mexico near San Diego.

Is The Mission Within a public or private company?

The Mission Within is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was The Mission Within founded?

The Mission Within was founded in 2017. It employs 11 to 50 people.

Where is The Mission Within based?

The Mission Within is headquartered in Austin, United States, in the North America region.

How does The Mission Within make money?

Two revenue lines are on record. Clinical Treatment Program Fees are the primary driver. The others are donations and Foundation Support.

Who are The Mission Within's main competitors?

Emerging players on record are MindMed, Compass Pathways and atai Life Sciences. Others are Stanford Psychedelic Science Group and Multidisciplinary Association for Psychedelic Studies (MAPS). Mindbloom is listed as a broad incumbent. Direct peers are Beond Ibogaine, Clear Sky Recovery and Field Trip Health (now Field Trip). Veterans Healing Network (Cohen Veterans Network) is listed as a regional player.

Does The Mission Within have an API?

No public API is recorded for The Mission Within.

What industry is The Mission Within in?

The Mission Within's product category is Psychedelic Therapy Services. Its primary akta.pro industry code is THAGAMAG, Rehabilitation & Recovery Retreats (Physio, Post-Op, Pain Management), with a secondary code of THAGAMAI, Holistic & Alternative Therapy Retreats (Naturopathy, Energy Work). Its NAICS code is 623220 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales